Clinical Trials Browser

Phase EARLY_PHASE1 × Withdrawn × Bevacizumab × Clear all

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT01331616 2021-12-09

Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab

Phase EARLY_PHASE1 Withdrawn

Glioblastoma, Optic Nerve Diseases